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Background: Liver steatosis was caused by lipid accumulation in the liver. Alisma orientale (AO) is recognized as a
promising candidate with therapeutic efficacy for the treatment of nonalcoholic fatty liver disease (NAFLD). HepG2
hepatocyte cell line is commonly used for liver disease cell model.
Method: The HepG2 cells were cultured with the NEFAs mixture (oleic and palmitic acids, 2:1 ratio) for 24 h to
induce hepatic steatosis. Then different doses of Alisma orientale extract (AOE) was treated to HepG2 for 24 h.
Incubated cells were used for further experiments.
Results: The AOE showed inhibitory effects on lipid accumulation in the Oil Red O staining and Nile red staining
tests with no cytotoxicity at a concentration of 300 μg/mL. Fatty acid synthase (FASN) and acetyl-CoA carboxylase 1
(ACC1) mRNA and protein expression level were down-regulated after AOE treatment. Bcl-2 associated X protein
(Bax) and c-Jun N-terminal kinase (JNK) mRNA expression level were decreased as well as p-JNK (activated form of
JNK), Bax, cleaved caspase-9, caspase-3 protein expression level. Anti-apopototic B-cell lymphoma 2 (Bcl-2) protein
level increased after AOE treatment. In addition, inflammatory protein expression including p-p65, p65, COX-2 and
iNOS were inhibited by AOE treatment.
Conclusion: The results suggest that AOE has anti-steatosis effects that involve lipogenesis, anti-lipoapoptosis, and
anti-inflammation in the NEFA-induced NAFLD pathological cell model.
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InflammationBackground
Hepatic steatosis has been defined chemically as an intra-
hepatic triglyceride (TG) content that is more than 5 % of
the liver volume or weight, and histologically as more than
5 % of the hepatocytes containing visible intracellular TG
[1, 2]. Nonalcoholic fatty liver disease (NAFLD) stands for
a spectrum of diseases ranging from simple steatosis to
steatohepatitis through to fibrosis and cirrhosis [3]. Al-
though the prevalence of NAFLD varied between different
regions an countries, the accepted global prevalence is* Correspondence: komclive@khmc.or.kr; hjjang@khu.ac.kr
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hepatitis (NASH) [4]. In Korea, according to a study using
sonography surveys, it is estimated that 28.1 % of the Ko-
rean nondiabetic population suffers from NAFLD [5]. The
reported risk factors for NAFLD include obesity, insulin
resistance, hyperlipidemia, and hyperglycemia [6] and the
increasing prevalence of obesity makes NAFLD a potential
emerging pandemic [7].
Lipoapoptosis is a term representing a pathogenic
phenomenon induced when non-esterified fatty acids
(NEFAs) overwhelm the esterifying capacity of the liver.
Excessive NEFAs may induce lipotoxicity including the
promotion of apoptosis and, therefore, the phenomenon
is termed lipoapoptosis [8, 9].le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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(FA) input outweighs the output. de novo lipogenesis
(DNL), one of the FA input components, is concerned
with the FA synthesis mechanism of the liver [2]. And
fatty acid synthase (FASN) and acetyl-CoA carboxylase 1
(ACC1) are the key genes associated with DNL [10].
Saturated NEFA causes cell death via sustained activation
of the c-Jun N-terminal kinase (JNK). Through several
complex processes, activated JNK activates Bcl-2-associated
X protein (BAX), a multidomain proapoptotic member of
the B-cell lymphoma 2 (Bcl-2) family, which then translo-
cates to the mitochondria, causing its dysfunction and
caspase-dependent cell death [11].
Nuclear factor kappa-light-chain-enhancer of activated
B cells (NF-kB), which is a key transcription factor that
regulates the genes related to the immune response and
inflammation is activated by NEFA induction. Dysregula-
tion of the NF-kB pathway plays an essential role in many
diseases such as inflammatory diseases, cancer, and ath-
erosclerosis [12, 13].
Alisma orientale (AO) has been known to have anti-
inflammatory and diuretic effects in traditional medicine
[14] and is prescribed to treat diseases including inhib-
ited urination, edema, strangury disease, disease associ-
ated with fluid retention [15]. Several previous studies
have reported the therapeutic efficacy of AO in NAFLD.
The aqueous extract of AO showed anti-apoptotic and
inhibitory effects against cellular steatosis and reactive
oxygen species (ROS) production in a palmitate-induced
cellular model [15, 16]. The 80 % ethanol extract of AO
had been reported to show hepatocellular protective ef-
fects mediated by the regulation of apoptosis-related
proteins [17].
In this study, additional attempt was made to reveal
effects against pathological mechanisms including lipid
accumulation, lipoapoptosis and inflammation induced
by NEFA. HepG2 cells were treated with the 30 % etha-
nol Alisma orientale extract (AOE) and a 3-(4,5-dimeth-
ylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
assay was performed to determine the safe concentration.
In addition, Oil Red O staining and Nile red staining were
performed to visually assess the effect of AOE against hep-
atocyte lipid accumulation. Furthermore, mRNA real-time
quantitative polymerase chain reaction (qPCR) and western
blot analysis were performed to evaluate NAFLD related
factors including ACC1 and FASN markers including DNL,
Bcl-2, BAX, JNK, caspase-3, and −9 and key molecules of
inflammation associated with p-65, COX-2, and iNOS.
Method
Materials
Dulbecco’s modified Eagle’s medium (DMEM), and fetal
bovine serum (FBS) were purchased from Lonza (Walkers-
ville, MD, USA). Bovine serum albumin (BSA) waspurchased from RMBIO (6015 Greg`s Way Missoula, MT,
USA, Cat# : BSA-BLP-1XG). Oil Red O, oleic and palmitic
acids (Cat# : O0625-25G), Nile red (Cat# : N3013-100MG),
and the MTT (Cat# : M2003-1G) were purchased from
Sigma-Aldrich (Saint Louis, MO, USA). The total RNA iso-
lation and cDNA synthesis kits were purchased from Gen-
eAll Bioscience (Seoul, Korea, Cat# : 305–101). The SYBR
green master mix was purchased from Life Technolo-
gies (Carlsbad, CA, USA, Cat# : 43676569). BAX (Cat# :
ab10813) and Bcl-2 (Cat# : ab59348) antibodies were pur-
chased from Abcam (Cambridge, UK). JNK (Cat# : 9252),
p-JNK (Cat# : 9251), caspase-9 (Cat# : 9502), cleaved
caspase-9 (Cat# : 9501), caspase-3 (Cat# : 9665), and
cleaved caspase-3 (Cat# : 9661) antibodies were purchased
from Cell Signaling Technology (Danvers, MA, USA). β-
actin (Cat# : sc-47778) and FASN (Cat# : 55580) antibodies
were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). The enhanced chemiluminescence (ECL)
solution (Luminata™ crescendo western horseradish perox-
idase, HRP substrate, Cat# : WBLUR0100) was purchased
from Merck Millipore (Jeffrey, NH, USA).
Herbal extraction
The Alisma orientale was obtained from the Kyung Hee
Oriental Herbal Medicine Research Center (Seoul,
Korea) [18]. Alisma orientale was purchased by Omni-
herb (Yeoncheon, South Korea), which had sale as a na-
tionally authorized distribution enterprise of herbal
medicine. The product number of Alisma orientale was #:
DH1602025041K. The preparation of the samples is de-
scribed in the cited references excluding the solvent com-
position [19, 20]. Alisma orientale was ground to the
appropriate particle size and extracted in 30 % ethanol.
Then, ultrasound-assisted extraction was performed twice
at 40 °C for 3 h. The extracted Alisma orientale sample was
filtered, and continuously evaporated using a rotary evapor-
ator. The dried Alisma orientale extracts powder was used
in this experiment.
Cell culture
HepG2 cells were obtained from the Korea Cell Line
Bank (Seoul, Korea). The cells were maintained in
DMEM supplement with 10 % FBS, 1 % antibiotics and
antimycotic (ABAM) solution, and then incubated at
37 °C in a 5 % CO2 humidified atmosphere [21]. For the
experiments, the cells were seeded in a 24-well cell cul-
ture plate at a density of 5 × 105 cells per well and incu-
bated for 16 h, and then washed with PBS and incubated
with low glucose DMEM for 12 h for serum starvation.
Then, the medium was changed to DMEM with 0.5 mM
NEFA (0.33 mM oleic acid and 0.17 mM palmitic acid)
(with 1 % BSA), and the cells were incubated further for
24 h to induce the hepatosteatotic condition. Then, the
medium was changed to DMEM containing 10 % FBS,
Table 1 List of real time PCR primer sequence
Gene Forward primer Reverse primer
GAPDH GCCAC ATCGC TCAGA CACC CCCAA TACGA CCAAA TCCGT
BAX CACCA AGGTG CCGGA ACT TCCCG GAGGA AGTCC AATG
BCL-2 CATGT GTGTG GAGAG CGTCA A GCCGG TTCAG GTACT CAGTC A
MAPK8 TGGTC AGCAG GGTGT CACA TCGCA GAGGG AGAAA AGCAA




FASN CGCTC GGCAT GGCTA TCT CTCGT TGAAG AACGC ATCCA
ACC1 GGATG GTGTT CACTC
GGTAA TAGA
GGGTG ATATG TGCTG CGTCA T
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were incubated further for 24 h.
Cell viability assay
Cell viability was measured using the MTT assay. The
cells were seeded (10 × 103 cells/well) in a 96-well cell
culture plate, incubated for 48 h, and then treated with
different concentrations of AOE (1, 10, 50, 100, 300,
500, 1000 μg/mL) for 24 h. The MTT was dissolved at
1 mg/mL in phosphate-buffered saline (PBS). After incu-
bation, the medium was discarded, and the cells were
treated with 100 μL of MTT solution for 1 h. Then the
solution was removed, and dimethyl sulfoxide (DMSO)
was added to dissolve the insoluble formazan crystal,
which were measured at an absorbance of 570 nm using
a Bio-Rad model 680 microplate reader [22].
Oil red O staining
The steatosis-induced HepG2 cells were washed with
ice-cold PBS to remove unbound stain, and then fixed in
ice-cold 10 % formalin for 30 min. The cells were then
washed with distilled water, and stained for 30 min with
0.3 % Oil Red O solution (in 60 % isopropanol) at room
temperature for the stain lipid droplets to form. The
stained cells were washed with running tap water for
2 min, and immediately counterstained with Harris’s
hematoxylin before cell drying. The cells were observed
and photographed using an optical microscope (Olym-
pus IX71).
Nile red staining
The cells were washed with ice-cold PBS, fixed for
30 min in ice-cold 10 % formalin, washed with PBS, then
stained with 0.3 nM Nile red solution (in PBS) for
15 min in a dark room. After staining, the Nile red solu-
tion was removed, and the cells were washed with PBS,
suspended in PBS, and collected in a polystyrene flow
cytometry sample tube. The stained cell lipid was deter-
mined by measuring the fluorescence using the FACSca-
libur flow cytometer (BD Bioscience) and analyzed using
the Cellquestpro (BD Bioscience).
Real-time quantitative PCR
Total RNA was isolated from HepG2 cells using a
RiboExtm kit (Geneall). A quantified 1-μg sample of total
RNA was used to synthesize cDNA using a Legene 1st
strand Express cDNA synthesis system kit (Legene Bio-
science). The mRNA expression level was determined via
qPCR according to the manufacturer’s manual. Among the
results, the 2-ΔΔCT values were used to compare the
groups and glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) was used as the endogenous control [23]. The se-
quences of the gene mRNA primers are shown in Table 1.Western blotting
The cells were washed, scraped into ice-cold PBS, and then
incubated in radioimmunoprecipitation (RIPA) assay buffer
with NP-40 and protease inhibitor cocktail for 1 h on ice
for cell lysis. After lysis, a Bradford assay was performed to
ensure the cell lysates contained the same protein quan-
tities. Each protein (10 μg samples) was separated according
to size using 10 % sodium dodecyl sulfate (SDS)-polyacryl-
amide gel electrophoresis (PAGE), and then transferred to a
polyvinylidene fluoride (PVDF) membrane. The membrane
was incubated with primary antibodies diluted 1:3000 in
Tris-buffered saline-Tween (TBS-T) and the secondary
antibody (1:10000 in TBS-T) in that order [24]. The protein
blot was detected with the ECL solution using a Davinci-
chemi chemiluminescence system (Davinch-K). The inten-
sity of the protein blot was measured and calculated using
the ImageJ software (NIH).
Identification of AO30 compound
The analysis was performed in the Korea Basic Science In-
stitute (Seoul, Korea). The system consisted of an Infinity
1290 ultra-performance liquid chromatography (UPLC)
system and an electrospray ionization (ESI) quadruple
time-of-flight (QTOF) mass spectrometer (MaS) (G6550A,
Agilent, CA, USA). A supelco ascientis express c18 col-
umn (1.7 μm, 150 mm× 2.1 mm i.d.) was used as an ana-
lytical column. The column was maintained at 40 °C. The
total running time, including the conditioning of the col-
umn to the initial conditions, was 50 min. The injection
volume was 1 μL. The ESI-QTOF-MaS instrument was
operated in the positive and negative ion mode using a
dual agilent jetstream electrospray ionization source. The
desolvation gas was set to a flow rate of 720 L/h at a
temperature of 350 °C. The source temperature was set to
100 °C. The capillary voltage was set to 4000 V.
Statistical analysis
All data represent at least two separate experiments per-
formed in triplicate. The significance of the data was ana-
lyzed using the Prism 5 software with a one-way analysis of
variance (ANOVA), Bonferroni’s post hoc test, and
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means ± standard error of the means (SEM). Significance
was denoted as follows, *p < 0.05, **p < 0.01, and ***p < 0.001.
Results
Effects of AOE on HepG2 cell viability
Alisma orientale extracts (AOE) has clinically used to
prescribe main component on inflammatory disease in
Korean medicine. Even if clinical trials treated with AOE
on prescription had not found, safe evaluation should
need to research on experimental human hepatic system.
To determine the cytotoxicity of AOE on human hepatic
cell line, we performed MTT assay on HepG2 cell line
(Fig. 1). Treatment of HepG2 cells with different concen-
trations (1–300 μg/mL) of AOE for 24 h did not signifi-
cantly decrease the cell viability compared to the control
group. On the other hand, high doses of AOE (500 and
1000 μg/mL) significantly decreased cell viability.
Effects of AOE and NEFA on HepG2 cell lipid
accumulation
To determine if AOE decreased the hepatocyte lipid accu-
mulation in NEFA-induced steatotic conditioned HepG2
cells [25], Oil Red O staining and Nile red staining were
performed. In the Oil Red O staining (Fig. 2), the HepG2
cells accumulated lipid droplets were stained red. Com-
pared with the control, the NEFA-treated HepG2 cells
showed an increase in cell lipid accumulation (arrows). In
addition, after the AOE treatment, the cell lipid decreased
dose-dependently (50, 100, and 300 μg/mL). Also, to quan-
tify the cell lipid content, the Nile red staining assay was
performed, and the fluorescence count was determined
using flow cytometry (Fig. 3). The relative fluorescenceFig. 1 Cell viability assay showing cytotoxicity of Alisma orientale
extract (AOE) in HepG2 cells. HepG2 cells were treated with different
concentration of AOE for 24 h, and then MTT assay was performed
to measure cell viability. Values are mean ± SEM. Statistical significant
was determined using one-way ANOVA test, *p < 0.05 compared to
control; ***p < 0.001intensity (Fig. 3) shows that cell lipid droplets decreased fol-
lowing AOE treatment. However, the effect was only sig-
nificant at a concentration of 300 but not of 100 μg/mL.
Effects of AOE on HepG2 cell lipogenesis related mRNA
and protein expression
To reveal the pathway involved in the AOE-mediated
decrease in hepatocyte lipid accumulation, a qPCR was
performed. FASN and ACC1 protein are related to the
cell lipid accumulation and lipogenesis induced by NEFA
[26]. Compared with control, the NEFA-treated group
showed a significantly increased mRNA expression. In
addition, the AOE-treated group showed significant in-
hibition of FASN and ACC1 expressions (Fig. 4a and b).
Down-regulation of cell lipoapoptosis-related mRNA and
protein expression by AOE in HepG2 cells
FASN and ACC1 protein expressions (Fig. 5a) were in-
creased in the NEFA-treated group compared to the con-
trol group. In addition, the AOE-treated group showed
down-regulation of FASN and ACC1 protein expression
compared to the NEFA-treated group (Fig. 5a). In addition,
the protein expression intensity (Fig. 5b) of FASN and
ACC1 in the AOE-treated group was more significantly
decreased than the group treated with NEFA. JNK protein
causes potential cellular damage via the lipoapoptosis
pathway following its activation by NEFA accumulation in
cells. NEFA also increases beta-oxidation in the cell mito-
chondria and induces the release of cytochrome C, thereby
triggering the lipoapoptosis pathway [27, 28]. Compared
with the control, the NEFA-treated group showed a signifi-
cant increase in the mRNA expression of BAX, Bcl-2, and
mitogen-activated protein kinase (MAPK) 8 (JNK mRNA,
Fig. 6a, b, and c) but not caspase-9 (Fig. 6d). In addition,
the AOE-treated group showed a significant inhibition of
BAX and MAPK8 (Fig. 6a and c) but no significant change
in Bcl-2 protein expressions. Phosphorylated (p)-JNK pro-
tein expression (Fig. 7) was increased when HepG2 cells
were treated NEFA and this effect was decreased following
AOE treatment. Other cell apoptosis-related proteins in-
cluding BAX showed increased expression in the NEFA-
treated group while Bcl-2 protein expression was sup-
pressed. In addition, the AOE-treated cells showed not
only down-regulation of BAX expression, but also up-
regulation of Bcl-2 expression. Caspase-3 is activated by
caspase-9 [24–29], and the levels of both cleaved forms in-
creased in NEFA-treated cells and decreased following
AOE treatment.
Effects of AOE on inflammatory protein expression in
HepG2 cells
The NF-kB p65 (p65) is a well-known cell inflammatory
protein, which can be activated by NEFA [13]. Among
the result of inflammatory protein expression (Fig. 8), p-
Fig. 2 Oil Red O staining of HepG2 Cells. Inhibitory effect of AOE on lipid accumulation in HepG2 cell line. Red dot (arrowhead) shows
lipid droplet; pale blue circle shows cell nucleus. Cells were starved for 12 h, then treated with 0.5 mM NEFA for 24 h, and then AOE
for 24 h. Cells were observed under magnification of 100×, scale bar, 20 μm. AOE, Alisma orientale extract; NEFA, non-esterified
fatty acid
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pared to the control, and the AOE-treated group
showed a decrease in p-p65 and COX-2 protein ex-
pression. In addition, p65 and inducible nitric oxide
synthase (iNOS) protein expression was not different
between the NEFA-treated and control groups but
the AOE-treated group showed a decreased in both
protein expressions.Fig. 3 Nile red staining of HepG2 Cells and quantitative analysis of lipids. In
red fluorescence was measured using flow cytometry. Fluorescence dot plo
compared to control, *p < 0.05, compared to NEFA-treated group. AOE, AlisHigh performance liquid chromatography (HPLC) of
Alisma orientale extracts
Alisol A, alisol A acetate, alisol B, and alisol B acetate were
the key ingredients of AO. We investigated whether the
experimental extract on AOE has the key ingredients by
using high performance liquid chromatography (HPLC).
The chromatogram result showed that AOE has alisol A,
alisal A acetate, alisol B, and alisol B acetate (Fig. 9).hibitory effect of AOE on lipid accumulation in HepG2 cell line. Nile
t and relative fluorescence graph. Values are mean ± SEM, ###p < 0.001,
ma orientale extract; NEFA, non-esterified fatty acid
Fig. 4 Bcl-2-associated X protein (BAX), and B-cell lymphoma 2 (Bcl-2) mRNA expression levels. Inhibitory effect of AOE on lipogenesis-related
mRNA expression in HepG2 cells. mRNA expression level was measured using SYBR green qPCR. Cells were starved for 16 h, treated with 0.5 mM
NEFA for 24 h, and then 300 μg/mL AOE for 24 h. Total RNA was then extracted and reverse transcribed using PCR and qPCR. Fatty acid synthesis-related
a, b gene expression level was calculated using GAPDH expression level as an internal control. Statistical significancy was determined using Student’s t-
test. Values are mean ± SEM, ##p < 0.01 compared to control, ###p< 0.001, ***p< 0.01 compared to NEFA-treated group. AOE, Alisma orientale extract; NEFA,
non-esterified fatty acid; qPCR, real-time polymerase chain reaction; GAPDH, glyceraldehyde 3-phosphate dehydrogenase
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This study was designed to investigate the anti-steatotic
effects of AOE using NEFA-induced HepG2 cells as lipo-
genesis markers that contribute to lipid accumulation. In
addition, the anti-lipoapoptotic and anti-inflammatory
effects of AOE were also investigated in the same cell
line model. To determine the cytotoxicity of AOE, the
MTT assay was performed. In addition, the Oil Red O
staining and Nile red staining were used to determine
the inhibitory effects of AOE on hepatocyte lipidFig. 5 Fatty acid synthase (FASN) and acetyl-CoA carboxylase 1 (ACC1) pro
AOE in HepG2 cells. Cell lysates were obtained using NP40 lysis buffer and
proteins were transferred to PVDF membrane. a Western blots were attach
were detected using Davinci-K chemiluminescence detector. b The dectec
blot was performed in triplicate. β-actin protein was used as an internal co
are mean ± SEM, #p < 0.05 compared to control, *p < 0.05 compared to NEF
fatty acid; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoaccumulation. Furthermore, we sought to determine if
the pathway mediating the effects of AOE involves the
reduction of hepatocyte lipid accumulation, lipoapopto-
sis, and inflammation as they relate to the progression
from simple steatosis to NASH. NASH is characterized
histologically by hepatic steatosis with evidence of liver
cell inflammation and injury (ballooning degeneration)
[30]. Although the mechanisms underlying the progres-
sion from steatosis to NASH is still not fully elucidated,
increasing evidence suggests that oxidative stress, whichtein expression levels. Lipogenesis-related protein regulatory effects of
15 μg of protein was loaded on a 12 % SDS-PAGE gel. After separation,
ed by anti-FASN or anti-ACC1 respectively and their attached proteins
ted proteins of FASN or ACC1 were described by bar graph. Western
ntrol. Statistical significant was determined using Student’s t-test. Values
A-treated group. AOE, Alisma orientale extract; NEFA, non-esterified
resis
Fig. 6 Mitogen-activated protein kinase (MAPK) 8, caspase-9 mRNA expression levels, Fatty acid synthase (FASN) and acetyl-CoA carboxylase 1
(ACC1). Inhibitory effect of AOE on lipoapoptosis-related mRNA expression in HepG2 cells. The mRNA expression level was measured using SYBR
green qPCR. Cells were starved 16 h, treated with 0.5 mM NEFA for 24 h, and then with 300 μg/mL AOE for 24 h. Total RNA was then extracted
reverse transcribed using PCR and qPCR. a-d, Lipoapoptosis-related gene expression level was calculated using GAPDH expression level as an internal
control. Statistical significant was determined using Student’s t-test. Values are mean ± SEM, #p < 0.05 compared to control, ##p < 0.01, *p< 0.05 compared
to NEFA-treated group, **p< 0.01. qPCR, real-time polymerase chain reaction; AOE, Alisma orientale extract; NEFA, non-esterified fatty acid;
GAPDH, glyceraldehyde 3-phosphate dehydrogenase
Fig. 7 Lipoapoptosis-related protein expression levels. Apoptosis-related
protein regulatory effects of AOE in HepG2 cells. Cell lysates
were obtained using NP40 lysis buffer, and 15 μg of protein was
loaded on a 12 % SDS-PAGE gel. After separation, proteins were
transferred onto a PVDF membrane. Protein blot was detected
using a Davinci-K chemiluminescence detector. β-actin protein was used
as an internal control. AOE, Alisma orientale extract; SDS-PAGE, sodium
dodecyl sulfate-polyacrylamide gel electrophoresis
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appropriately removed, is a key driving force in trigger-
ing inflammatory signaling pathways that promote the
progression of simple steatosis to NASH [26–32]. There-
fore, mRNA qPCR and western blot were performed to
evaluate the expression of the specific mRNA and pro-
teins involved in these phenomena.
The MTT assay was used to determine the AOE con-
centrations that safe for use in this study. ConcentrationFig. 8 Inflammatory protein expression levels. Inflammatory protein
regulatory effect of AOE in HepG2 cells. Cell lysates were obtained using
NP40 lysis buffer and 15 μg of protein was loaded on a 12 % SDS-PAGE
gel. After separation, proteins were transferred to a PVDF membrane.
Protein blot was detected using a Davinci-K chemiluminescence
detector. β-actin protein was used as an internal control. AOE,
Alisma orientale extract; SDS-PAGE, sodium dodecyl sulfate-
polyacrylamide gel electrophoresis
Fig. 9 AO30 high performance liquid chromatography. AO30 sample was diluted in 30 % ethanol; the vehicle liquid contained distilled water and
acetonitrile. AO30 HPLC results showed that AO30 has alisol A, alisal A acetate, alisol B, and alisol B acetate
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crease in the viability of the treated HepG2 cells com-
pared to the control group. However, higher doses of
AOE (500 and 1000 μg/mL) significantly decreased the
cell viability (Fig. 1). In previous studies using the 80 %
ethanol AOE, 100 μg/mL had no significant cytotoxicity
while concentrations of 500 and 1000 μg/mL of AOE
caused a significant decrease in cell viability [17], similar
to our result. Based on this result, a concentration of
300 μg/mL of AOE could be used in future experiments.
FAs are classified chemically as saturated and unsatur-
ated (monounsaturated and polyunsaturated), and their
structures affect their biological activity [33]. Saturated
fatty acids (SFAs) are known to induce lipotoxicity such as
insulin resistance and cell death. Palmitic and oleic acids
are a typical SFA and monounsaturated fatty acid (MUFA),
respectively [34]. In a study of the differential effects of
these FAs on apoptosis and lipid accumulation in cultured
hepatocytes, oleic acid was revealed to be more steatogenic
but less apoptotic than palmitic acid was. Incubation with
both FAs resulted in a higher amount of fat accumulation
than with palmitic acid alone, but the apoptosis was lower,
indicating a protective feature for oleic acid [33]. A proper
ratio of palmitic and oleic acids in a combination mixture
leads to significant lipoapoptosis and intracellular lipid ac-
cumulation with minimal cellular damage [18, 19]. In one
study, NEFAs composed of oleic and palmitic acids (2:1),maximized lipid accumulation without causing severe cel-
lular toxicity [35] and a 0.5 mM mixture of NEFAs in the
same ratio showed sufficient lipid accumulation in HepG2
cell in the Oil Red O and Nile red staining tests. Based on
these results, the study design used a combination NEFA
consisting of oleic acid and palmitic acid in a 2:1 molar ra-
tio for developing the pathological cell model of NAFLD.
In the Oil Red O staining test, AOE reduced the
0.5 mM NEFA-induced cell lipid accumulation dose-
dependently up to a concentration of 300 μg/mL (Fig. 2).
The Nile red staining was performed using flow cytometry
to quantify the cell lipid accumulation, and the relative
fluorescence intensity showed that the cell lipid decreased
significantly following treatment with 300 but not 50 or
100 μg/mL concentrations of AOE (Fig. 3). This result
suggests that 300 μg/mL of AOE has an effect on lipid ac-
cumulation in HepG2 cells without any cell toxicity.
The possible sources of the fats that are responsible
for hepatic steatosis are peripheral fats contained in adi-
pose tissue, which flow to the liver via the plasma NEFA
pool, FAs newly formed in the liver by DNL, and dietary
FAs. DNL is an endogenous pathway, which converts
carbohydrates and proteins to NEFAs [2]. Furthermore,
in the fasting state, roughly one-fourth of all the FAs are
newly made via DNL [36]. FASN and ACC1 are key
genes associated with DNL [10] and regulated by sterol
regulatory element-binding protein (SREBP)-1c. ACC1
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synthesize palmitic acid, and it is possible to synthesize
oleic acid by successive elongation and desaturation pro-
cesses [32–37]. We investigated the inhibitory effects of
AOE on the mechanism of DNL-mediated lipid accumu-
lation using qPCR and western blotting to determine
mRNA and protein levels. The NEFA-treated group
showed a higher increased in the expression of FASN
and ACC1 than the control group did. And the AOE-
treated group showed higher down-regulation of FASN
and ACC1 protein expression than the 0.5 mM NEFA-
treated group did (Figs. 4 and 5). This result suggests
that the effect of AOE on lipid accumulation is associ-
ated with the DNL process.
Factors related to lipoapoptosis, the pathological
phenomenon induced by lipid accumulation were deter-
mined following the treatment of HepG2 cells with
0.5 mM NEFA and 300 μg/mL of AOE. When NEFAs
penetrate cells, JNK is activated and the JNK protein, which
is the central mediator of saturated NEFA induced hepato-
cyte apoptosis [38], and can causes potential cellular dam-
age via the cellular apoptosis pathway [19, 28]. The JNK
signaling pathway has been reported to affect members of
the Bcl-2 family. Specifically, JNK can activate the mito-
chondrial translocation of BAX and inactivate anti-
apoptotic Bcl-2 proteins [24–29]. BAX translocates to the
mitochondria and thereby facilitates the release of the mito-
chondrial cytochrome C protein into the cytosol, which
then interacts with procaspase-9, switching on caspase-3,
to induce apoptosis [24–29, 34–39]. At the mRNA level,
the AOE-treated group showed a more significant inhib-
ition of BAX and MAPK8 expression but not caspase-9
than the 0.5 mM NEFA-treated group did. Protein expres-
sion levels of p-JNK (activated form of JNK), BAX, as well
as cleaved caspase-9 and caspase-3 were more decreased in
the AOE-treated HepG2 cells than they were in the
0.5 mM NEFA-treated cells, which corresponds to a previ-
ous study using 100 μg/mL of 80 % ethanol AOE and
1 mM mixed NEFAs in the same ratio [17]. The AOE treat-
ment significantly affected Bcl-2 and caspase-9 protein ex-
pression levels (Figs. 6 and 7). Based on these result, the
anti-lipoapoptosis was mediated via the JNK signaling path-
way on HepG2 cell line treated with AOE.
NF-kB is known to play a critical role in the regulation of
cell survival genes and coordination of pro-inflammatory
mediators. NF-kB regulates the expression of iNOS, a pro-
inflammatory enzyme that is involved in the production of
nitric oxide (NO) at the transcriptional level [40, 41]. NF-kB
also regulates COX-2, the key enzyme regulating the pro-
duction of prostaglandins, which are central mediators of
inflammation [42]. The p-p65 and COX-2 protein expres-
sion was more highly increased in the NEFA group than the
control group. But, exposing the group treated with AOE
showed remarkably decrease in their inflammatory proteinexpression. In summary, AOE was revealed to have anti-
inflammatory effects in HepG2 cells.
From the result presented, AOE showed anti-steatosis ef-
fects mediate via lipogenesis, anti-lipoapoptosis, and anti-
inflammatory mechanisms in the NEFA-induced NAFLD
pathological cell model. We observed that AOE contributed
not only to inhibiting simple steatosis, but also NASH based
on the experiments involving lipoapoptosis and inflamma-
tion, which are factors involved in the progression of
NAFLD. The described effects of AOE derived from
Alisol A, Alisol acetate, Alisol B, and Alisol B acetate.
Using the components of AOE, Alisol A, Alisol acet-
ate, Alisol B, and Alisol B acetate need to discovery
an individual pharmacological capacity in lipoapopto-
sis and anti-inflammation reageant.
Conclusion
The anti-steatotic effects of AOE involving lipogenesis,
anti-lipoapoptosis, and anti-inflammation in NEFA-
induced HepG2 cells using the MTT assay, Oil Red O
staining, Nile red staining, mRNA qPCR, and western
blotting were investigated in this study. The summary of
the results obtained is as follows,
1. AOE concentrations of up to 300 μg/mL caused no
significant decrease in the viability of HepG2 cells
compared to the control group.
2. AOE inhibited lipid accumulation in the Oil red O
staining test and moreover, the Nile red staining
test, which particularly enabled the quantification of
cell lipid using flow cytometry, showed that cell lipid
was decreased significantly following AOE treatment
only at a concentration of 300 μg/mL.
3. AOE treatment down-regulated FASN and ACC1
protein expressions more than treatment with
0.5 mM NEFA did, and NEFA-treated cells showed
a higher increase in the mRNA and protein expression
levels of FASN and ACC1 than the control group cells.
4. AOE-treated HepG2 cells showed a significant
inhibition of BAX and MAPK8 mRNA expression
levels and of p-JNK (activated form of JNK) and
BAX as well as cleaved caspase-9 and caspase-3
protein levels. Bcl-2 and caspase-9 protein but not
mRNA expression levels were significantly affected
by AOE treatment.
5. AOE- treated HepG2 cells showed decreased
inflammatory protein expression including p-p65,
COX-2, p65, and iNOS.
6. AOE was analyzed including in Alisol A, Alisol A
acetate, Alisol B, Alisol B acetate by high performance
liquid chromatography.
Based on these results, AOE is considered to have
anti-steatosis effects, which involve lipogenesis, anti-
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NEFA-induced NAFLD pathological cell model. In the
present study, AOE inhibited not only simple steatosis,
but also the progression of the disease as evidenced by the
results of the experiment involving lipoapoptosis and in-
flammation. Therefore, AO appears to be a potential can-
didate for development as a therapeutic option for the
treatment of NAFLD, as well as NASH, which are induced
by lipoapoptosis and inflammation.
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